Company Profiles

driven by the PitchBook Platform

AlloMek Therapeutics

Description

Developer of targeted therapies for cancer patients. The company has discovered a class of MEK kinase inhibitors that improve the bio pharmaceutical properties of previous MEK inhibitors.

2010

Founded

PRIVATE

Status

Seed

Latest Deal Type

$50k

Latest Deal Amount

$420k

Total Amount Raised

1

Investors

Description

Developer of targeted therapies for cancer patients. The company has discovered a class of MEK kinase inhibitors that improve the bio pharmaceutical properties of previous MEK inhibitors.

Website:

www.allomek.optimatrix.net

Formerly Known As

AlloStem Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

400 Farmington Avenue Farmington, CT 06032United States +1 (860) 679-6893
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AlloMek Therapeutics's full profile, request a free trial.

AlloMek Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AlloMek Therapeutics Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Connecticut InnovationsVenture CapitalMinority000 0000000 0000
Connecticut Innovations Venture Capital

AlloMek Therapeutics Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Barry Hart Ph.DCo-Founder, Project Manager and Director, Business Development
Uday Khire Ph.DChief Executive Officer & Co-Founder
Barry Hart Ph.D Co-Founder, Project Manager and Director, Business Development
Uday Khire Ph.D Chief Executive Officer & Co-Founder

AlloMek Therapeutics Board Members (1)

NameRepresentingRoleSinceContact
Info
Peter LongoConnecticut InnovationsBoard Member000 0000
Peter Longo Board Member Connecticut Innovations
Request full access to PitchBook